搜尋結果
CSPC PHARMA's US Clinical Trial Application for Highly Selective MAT2A Inhibitor Approved
AASTOCKS.com· 13 小時前... or warranties (including, without limitation, any warranty or merchantability or fitness for a particular purpose or use) regarding the Info ...
IBM Is Buying HashiCorp. What Comes Next?
Forbes· 17 小時前The rumours have been confirmed and IBM will acquire HashiCorp for $35 per share, subject to ...
Foot Locker Puts Faith In New Store Concept To Increase Sneaker Sales
Forbes· 17 小時前It has been a little over a year since highly-regarded former Ulta Beauty CEO Dillon ...
How To Incorporate Homemade Dog Food Into Your Pup’s Diet, According To Experts
Forbes· 17 小時前Like many pet guardians who strive to keep their furry companions as healthy as possible, you ...
Red Bull designer Newey wants out, but F1 team say he’s not going anywhere
South China Morning Post· 19 小時前Newey, whose cars have won 25 drivers’ and constructors’ championships for Williams, McLaren and Red Bull, could not be ...
Harvey Weinstein?s rape conviction is overturned by New York's top court - English News - ...
metroradio.com.hk· 1 日前New York’s highest court on Thursday threw out Harvey Weinstein ’s 2020 rape conviction with a ruling that shocked and disappointed ...
Meta could face further squeeze on surveillance ads model in EU
TechCrunch· 1 日前Meta’s tracking ads business could be facing further legal blows in the European Union: An ...
Italy abortion law changes criticized
China Daily· 2 日前A fiery debate has begun in Italy after the country's Senate approved a new law allowing what the legislation calls groups ...
Houston Astros’ Starting Rotation Injuries Reflect In MLB Standings
Forbes· 2 日前At the start of play April 25, the Houston Astros are mired in last place in the American ...
Council Post: Neurodivergence In The 21st Century: How Technology Supports Children's Potential
Forbes· 2 日前Dr. Sharief Taraman, MD, DABPN, DABPM, FAAP, is CEO of Cognoa, a leading early childhood ...